COVID-19 Acute Respiratory Distress Syndrome
78
3
6
39
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.6%
2 terminated out of 78 trials
95.1%
+8.6% vs benchmark
3%
2 trials in Phase 3/4
0%
0 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (78)
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Post Acute Sequelae of COVID-19
Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®
Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
Registry for Hemoperfusion of Covid-19 ICU Patients
Cerebral Autoregulation and COVID-19
Follow-up of Covid-19 Long Term Sequelae
Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19
Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)
Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
PRactice of Ventilation and Adjunctive Therapies in COVID-19 Patients.
T-Cell Mitochondrial Respiration Response to Ketone Monoester Supplement in Healthy Volunteers and COVID-19
Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome
Quality of Life 1y and 2 y After VV-ECMO for COVID-19
Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients
Personalized Targeted Immunomodulation in COVID-19 ARDS